Global and Japan Gabapentin Market Insights, Forecast to 2027

Global and Japan Gabapentin Market Insights, Forecast to 2027

Table of Contents
1 Study Coverage
1.1 Gabapentin Product Introduction
1.2 Market by Type
1.2.1 Global Gabapentin Market Size Growth Rate by Type
1.2.2 Capsule
1.2.3 Tablet
1.3 Market by Application
1.3.1 Global Gabapentin Market Size Growth Rate by Application
1.3.2 Epilepsy
1.3.3 Neuropathic Pain
1.3.4 Restless Legs Syndrome
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Gabapentin Market Size, Estimates and Forecasts
2.1.1 Global Gabapentin Revenue 2016-2027
2.1.2 Global Gabapentin Sales 2016-2027
2.2 Global Gabapentin, Market Size by Region: 2016 VS 2021 VS 2027
2.3 Gabapentin Historical Market Size by Region (2016-2021)
2.3.1 Global Gabapentin Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Gabapentin Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Gabapentin Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Gabapentin Sales Forecast by Region (2022-2027)
2.4.2 Global Gabapentin Revenue Forecast by Region (2022-2027)
3 Global Gabapentin Competitor Landscape by Players
3.1 Global Top Gabapentin Manufacturers by Sales
3.1.1 Global Gabapentin Sales by Manufacturer (2016-2021)
3.1.2 Global Gabapentin Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Gabapentin Manufacturers by Revenue
3.2.1 Key Gabapentin Manufacturers Covered: Ranking by Revenue
3.2.2 Global Gabapentin Revenue by Manufacturers (2016-2021)
3.2.3 Global Gabapentin Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Gabapentin Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Gabapentin Revenue in 2020
3.2.6 Global Gabapentin Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Gabapentin Price by Manufacturers
3.4 Global Gabapentin Manufacturing Base Distribution, Product Types
3.4.1 Gabapentin Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Gabapentin Product Type
3.4.3 Date of International Manufacturers Enter into Gabapentin Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2016-2027)
4.1 Global Gabapentin Market Size by Type (2016-2021)
4.1.1 Global Gabapentin Sales by Type (2016-2021)
4.1.2 Global Gabapentin Revenue by Type (2016-2021)
4.1.3 Gabapentin Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Gabapentin Market Size Forecast by Type (2022-2027)
4.2.1 Global Gabapentin Sales Forecast by Type (2022-2027)
4.2.2 Global Gabapentin Revenue Forecast by Type (2022-2027)
4.2.3 Gabapentin Average Selling Price (ASP) Forecast by Type (2022-2027)
5 Breakdown Data by Application (2016-2027)
5.1 Global Gabapentin Market Size by Application (2016-2021)
5.1.1 Global Gabapentin Sales by Application (2016-2021)
5.1.2 Global Gabapentin Revenue by Application (2016-2021)
5.1.3 Gabapentin Price by Application (2016-2021)
5.2 Gabapentin Market Size Forecast by Application (2022-2027)
5.2.1 Global Gabapentin Sales Forecast by Application (2022-2027)
5.2.2 Global Gabapentin Revenue Forecast by Application (2022-2027)
5.2.3 Global Gabapentin Price Forecast by Application (2022-2027)
6 Japan by Players, Type and Application
6.1 Japan Gabapentin Market Size YoY Growth 2016-2027
6.1.1 Japan Gabapentin Sales YoY Growth 2016-2027
6.1.2 Japan Gabapentin Revenue YoY Growth 2016-2027
6.1.3 Japan Gabapentin Market Share in Global Market 2016-2027
6.2 Japan Gabapentin Market Size by Players (International and Local Players)
6.2.1 Japan Top Gabapentin Players by Sales (2016-2021)
6.2.2 Japan Top Gabapentin Players by Revenue (2016-2021)
6.3 Japan Gabapentin Historic Market Review by Type (2016-2021)
6.3.1 Japan Gabapentin Sales Market Share by Type (2016-2021)
6.3.2 Japan Gabapentin Revenue Market Share by Type (2016-2021)
6.3.3 Japan Gabapentin Price by Type (2016-2021)
6.4 Japan Gabapentin Market Estimates and Forecasts by Type (2022-2027)
6.4.1 Japan Gabapentin Sales Forecast by Type (2022-2027)
6.4.2 Japan Gabapentin Revenue Forecast by Type (2022-2027)
6.4.3 Japan Gabapentin Price Forecast by Type (2022-2027)
6.5 Japan Gabapentin Historic Market Review by Application (2016-2021)
6.5.1 Japan Gabapentin Sales Market Share by Application (2016-2021)
6.5.2 Japan Gabapentin Revenue Market Share by Application (2016-2021)
6.5.3 Japan Gabapentin Price by Application (2016-2021)
6.6 Japan Gabapentin Market Estimates and Forecasts by Application (2022-2027)
6.6.1 Japan Gabapentin Sales Forecast by Application (2022-2027)
6.6.2 Japan Gabapentin Revenue Forecast by Application (2022-2027)
6.6.3 Japan Gabapentin Price Forecast by Application (2022-2027)
7 North America
7.1 North America Gabapentin Market Size YoY Growth 2016-2027
7.2 North America Gabapentin Market Facts & Figures by Country
7.2.1 North America Gabapentin Sales by Country (2016-2021)
7.2.2 North America Gabapentin Revenue by Country (2016-2021)
7.2.3 U.S.
7.2.4 Canada
8 Asia Pacific
8.1 Asia Pacific Gabapentin Market Size YoY Growth 2016-2027
8.2 Asia Pacific Gabapentin Market Facts & Figures by Region
8.2.1 Asia Pacific Gabapentin Sales by Region (2016-2021)
8.2.2 Asia Pacific Gabapentin Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
8.2.12 Philippines
8.2.13 Vietnam
9 Europe
9.1 Europe Gabapentin Market Size YoY Growth 2016-2027
9.2 Europe Gabapentin Market Facts & Figures by Country
9.2.1 Europe Gabapentin Sales by Country (2016-2021)
9.2.2 Europe Gabapentin Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy
10 Latin America
10.1 Latin America Gabapentin Market Size YoY Growth 2016-2027
10.2 Latin America Gabapentin Market Facts & Figures by Country
10.2.1 Latin America Gabapentin Sales by Country (2016-2021)
10.2.2 Latin America Gabapentin Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Gabapentin Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Gabapentin Market Facts & Figures by Country
11.2.1 Middle East and Africa Gabapentin Sales by Country (2016-2021)
11.2.2 Middle East and Africa Gabapentin Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E
12 Company Profiles
12.1 Pfizer
12.1.1 Pfizer Corporation Information
12.1.2 Pfizer Description and Business Overview
12.1.3 Pfizer Gabapentin Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Pfizer Gabapentin Products Offered
12.1.5 Pfizer Recent Development
12.2 Assertio Therapeutics
12.2.1 Assertio Therapeutics Corporation Information
12.2.2 Assertio Therapeutics Description and Business Overview
12.2.3 Assertio Therapeutics Gabapentin Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Assertio Therapeutics Gabapentin Products Offered
12.2.5 Assertio Therapeutics Recent Development
12.3 TEVA
12.3.1 TEVA Corporation Information
12.3.2 TEVA Description and Business Overview
12.3.3 TEVA Gabapentin Sales, Revenue and Gross Margin (2016-2021)
12.3.4 TEVA Gabapentin Products Offered
12.3.5 TEVA Recent Development
12.4 Mylan
12.4.1 Mylan Corporation Information
12.4.2 Mylan Description and Business Overview
12.4.3 Mylan Gabapentin Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Mylan Gabapentin Products Offered
12.4.5 Mylan Recent Development
12.5 Arbor Pharma
12.5.1 Arbor Pharma Corporation Information
12.5.2 Arbor Pharma Description and Business Overview
12.5.3 Arbor Pharma Gabapentin Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Arbor Pharma Gabapentin Products Offered
12.5.5 Arbor Pharma Recent Development
12.6 Novartis
12.6.1 Novartis Corporation Information
12.6.2 Novartis Description and Business Overview
12.6.3 Novartis Gabapentin Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Novartis Gabapentin Products Offered
12.6.5 Novartis Recent Development
12.7 Apotex
12.7.1 Apotex Corporation Information
12.7.2 Apotex Description and Business Overview
12.7.3 Apotex Gabapentin Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Apotex Gabapentin Products Offered
12.7.5 Apotex Recent Development
12.8 Sun Pharmaceutical
12.8.1 Sun Pharmaceutical Corporation Information
12.8.2 Sun Pharmaceutical Description and Business Overview
12.8.3 Sun Pharmaceutical Gabapentin Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Sun Pharmaceutical Gabapentin Products Offered
12.8.5 Sun Pharmaceutical Recent Development
12.9 Aurobindo Pharma
12.9.1 Aurobindo Pharma Corporation Information
12.9.2 Aurobindo Pharma Description and Business Overview
12.9.3 Aurobindo Pharma Gabapentin Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Aurobindo Pharma Gabapentin Products Offered
12.9.5 Aurobindo Pharma Recent Development
12.10 Intas
12.10.1 Intas Corporation Information
12.10.2 Intas Description and Business Overview
12.10.3 Intas Gabapentin Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Intas Gabapentin Products Offered
12.10.5 Intas Recent Development
12.11 Pfizer
12.11.1 Pfizer Corporation Information
12.11.2 Pfizer Description and Business Overview
12.11.3 Pfizer Gabapentin Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Pfizer Gabapentin Products Offered
12.11.5 Pfizer Recent Development
12.12 Marksans Pharma
12.12.1 Marksans Pharma Corporation Information
12.12.2 Marksans Pharma Description and Business Overview
12.12.3 Marksans Pharma Gabapentin Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Marksans Pharma Products Offered
12.12.5 Marksans Pharma Recent Development
12.13 Glenmark
12.13.1 Glenmark Corporation Information
12.13.2 Glenmark Description and Business Overview
12.13.3 Glenmark Gabapentin Sales, Revenue and Gross Margin (2016-2021)
12.13.4 Glenmark Products Offered
12.13.5 Glenmark Recent Development
12.14 Alkem
12.14.1 Alkem Corporation Information
12.14.2 Alkem Description and Business Overview
12.14.3 Alkem Gabapentin Sales, Revenue and Gross Margin (2016-2021)
12.14.4 Alkem Products Offered
12.14.5 Alkem Recent Development
12.15 Jiangsu Enhua
12.15.1 Jiangsu Enhua Corporation Information
12.15.2 Jiangsu Enhua Description and Business Overview
12.15.3 Jiangsu Enhua Gabapentin Sales, Revenue and Gross Margin (2016-2021)
12.15.4 Jiangsu Enhua Products Offered
12.15.5 Jiangsu Enhua Recent Development
12.16 Jiangsu Hengrui
12.16.1 Jiangsu Hengrui Corporation Information
12.16.2 Jiangsu Hengrui Description and Business Overview
12.16.3 Jiangsu Hengrui Gabapentin Sales, Revenue and Gross Margin (2016-2021)
12.16.4 Jiangsu Hengrui Products Offered
12.16.5 Jiangsu Hengrui Recent Development
12.17 Sailike
12.17.1 Sailike Corporation Information
12.17.2 Sailike Description and Business Overview
12.17.3 Sailike Gabapentin Sales, Revenue and Gross Margin (2016-2021)
12.17.4 Sailike Products Offered
12.17.5 Sailike Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Gabapentin Industry Trends
13.2 Gabapentin Market Drivers
13.3 Gabapentin Market Challenges
13.4 Gabapentin Market Restraints
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Gabapentin Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Global Gabapentin Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Capsule
Table 3. Major Manufacturers of Tablet
Table 4. Global Gabapentin Market Size Growth Rate by Application (2021-2027) & (M Unit)
Table 5. Global Gabapentin Market Size by Region (M Unit) & (US$ Million), 2016 VS 2021 VS 2027
Table 6. Global Gabapentin Sales by Regions (2016-2021) & (M Unit)
Table 7. Global Gabapentin Sales Market Share by Regions (2016-2021)
Table 8. Global Gabapentin Revenue by Regions (2016-2021) & (US$ Million)
Table 9. Global Gabapentin Sales Forecast by Region (2022-2027) & (M Unit)
Table 10. Global Gabapentin Sales Market Share Forecast by Region (2022-2027)
Table 11. Global Gabapentin Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 12. Global Gabapentin Revenue Market Share Forecast by Region (2022-2027)
Table 13. Global Gabapentin Sales by Manufacturers (2016-2021) (M Unit)
Table 14. Global Gabapentin Sales Share by Manufacturers (2016-2021)
Table 15. Ranking of Global Top Gabapentin Manufacturers by Revenue (US$ Million) in 2020
Table 16. Gabapentin Revenue by Manufacturers (2016-2021) (US$ Million)
Table 17. Gabapentin Revenue Share by Manufacturers (2016-2021)
Table 18. Global Gabapentin Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
Table 19. Global Gabapentin by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gabapentin as of 2020)
Table 20. Key Manufacturers Gabapentin Price (2016-2021) (USD/Unit)
Table 21. Gabapentin Manufacturers Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Gabapentin Product Type
Table 23. Date of International Manufacturers Enter into Gabapentin Market
Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 25. Global Gabapentin Sales by Type (2016-2021) (M Unit)
Table 26. Global Gabapentin Sales Share by Type (2016-2021)
Table 27. Global Gabapentin Revenue by Type (2016-2021) (US$ Million)
Table 28. Global Gabapentin Revenue Share by Type (2016-2021)
Table 29. Gabapentin Average Selling Price (ASP) by Type (2016-2021) & (USD/Unit)
Table 30. Global Gabapentin Sales Forecast by Type (2022-2027) & (M Unit)
Table 31. Global Gabapentin Sales Market Share Forecast by Type (2022-2027)
Table 32. Global Gabapentin Revenue Forecast V (2022-2027) & (US$ Million)
Table 33. Global Gabapentin Revenue Market Share Forecast by Type (2022-2027)
Table 34. Global Gabapentin Average Selling Price (ASP) Forecast by Type (2022-2027) & (USD/Unit)
Table 35. Global Gabapentin Sales by Application (2016-2021) (M Unit)
Table 36. Global Gabapentin Sales Share by Application (2016-2021)
Table 37. Global Gabapentin Revenue by Application (2016-2021) (US$ Million)
Table 38. Global Gabapentin Revenue Share by Application (2016-2021)
Table 39. Gabapentin Average Selling Price (ASP) by Application (2016-2021) & (USD/Unit)
Table 40. Global Gabapentin Sales Forecast by Application (2022-2027) & (M Unit)
Table 41. Global Gabapentin Sales Market Share Forecast by Application (2022-2027)
Table 42. Global Gabapentin Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 43. Global Gabapentin Revenue Market Share Forecast by Application (2022-2027)
Table 44. Global Gabapentin Average Selling Price (ASP) Forecast by Application (2022-2027) & (USD/Unit)
Table 45. Japan Gabapentin Sales (M Unit) of Key Companies (2016-2021)
Table 46. Japan Gabapentin Sales Share by Company (2016-2021)
Table 47. Japan Gabapentin Revenue (US$ Million) by Company (2016-2021)
Table 48. Japan Gabapentin Revenue Share by Company (2016-2021)
Table 49. Japan Gabapentin Sales (M Unit) by Type (2016-2021)
Table 50. Japan Gabapentin Sales Share by Type (2016-2021)
Table 51. Japan Gabapentin Revenue (US$ Million) Market Share by Type (2016-2021)
Table 52. Japan Gabapentin Price (USD/Unit) by Type (2016-2021)
Table 53. Japan Gabapentin Sales (M Unit) by Type (2022-2027)
Table 54. Japan Gabapentin Sales Share by Type (2022-2027)
Table 55. Japan Gabapentin Revenue (US$ Million) Market Share by Type (2022-2027)
Table 56. Japan Gabapentin Revenue Share by Type (2022-2027)
Table 57. Japan Gabapentin Price (USD/Unit) by Type (2022-2027)
Table 58. Japan Gabapentin Sales (M Unit) by Application (2016-2021)
Table 59. Japan Gabapentin Sales Share by Application (2016-2021)
Table 60. Japan Gabapentin Revenue (US$ Million) Market Share by Application (2016-2021)
Table 61. Japan Gabapentin Price (USD/Unit) by Application (2016-2021)
Table 62. Japan Gabapentin Sales (M Unit) by Application (2022-2027)
Table 63. Japan Gabapentin Sales Share by Application (2022-2027)
Table 64. Japan Gabapentin Revenue (US$ Million) Market Share by Application (2022-2027)
Table 65. Japan Gabapentin Revenue Share by Application (2022-2027)
Table 66. Japan Gabapentin Price (USD/Unit) by Application (2022-2027)
Table 67. North America Gabapentin Sales by Country (2016-2021) & (M Unit)
Table 68. North America Gabapentin Sales Market Share by Country (2016-2021)
Table 69. North America Gabapentin Revenue by Country (2016-2021) & (US$ Million)
Table 70. North America Gabapentin Revenue Market Share by Country (2016-2021)
Table 71. Asia Pacific Gabapentin Sales by Region (2016-2021) & (M Unit)
Table 72. Asia Pacific Gabapentin Sales Market Share by Region (2016-2021)
Table 73. Asia Pacific Gabapentin Revenue by Region (2016-2021) & (US$ Million)
Table 74. Asia Pacific Gabapentin Revenue Market Share by Region (2016-2021)
Table 75. Europe Gabapentin Sales by Country (2016-2021) & (M Unit)
Table 76. Europe Gabapentin Sales Market Share by Country (2016-2021)
Table 77. Europe Gabapentin Revenue by Country (2016-2021) & (US$ Million)
Table 78. Europe Gabapentin Revenue Market Share by Country (2016-2021)
Table 79. Latin America Gabapentin Sales by Country (2016-2021) & (M Unit)
Table 80. Latin America Gabapentin Sales Market Share by Country (2016-2021)
Table 81. Latin Americaa Gabapentin Revenue by Country (2016-2021) & (US$ Million)
Table 82. Latin America Gabapentin Revenue Market Share by Country (2016-2021)
Table 83. Middle East and Africa Gabapentin Sales by Country (2016-2021) & (M Unit)
Table 84. Middle East and Africa Gabapentin Sales Market Share by Country (2016-2021)
Table 85. Middle East and Africa Gabapentin Revenue by Country (2016-2021) & (US$ Million)
Table 86. Middle East and Africa Gabapentin Revenue Market Share by Country (2016-2021)
Table 87. Pfizer Corporation Information
Table 88. Pfizer Description and Business Overview
Table 89. Pfizer Gabapentin Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 90. Pfizer Gabapentin Product
Table 91. Pfizer Recent Development
Table 92. Assertio Therapeutics Corporation Information
Table 93. Assertio Therapeutics Description and Business Overview
Table 94. Assertio Therapeutics Gabapentin Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 95. Assertio Therapeutics Product
Table 96. Assertio Therapeutics Recent Development
Table 97. TEVA Corporation Information
Table 98. TEVA Description and Business Overview
Table 99. TEVA Gabapentin Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 100. TEVA Product
Table 101. TEVA Recent Development
Table 102. Mylan Corporation Information
Table 103. Mylan Description and Business Overview
Table 104. Mylan Gabapentin Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 105. Mylan Product
Table 106. Mylan Recent Development
Table 107. Arbor Pharma Corporation Information
Table 108. Arbor Pharma Description and Business Overview
Table 109. Arbor Pharma Gabapentin Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 110. Arbor Pharma Product
Table 111. Arbor Pharma Recent Development
Table 112. Novartis Corporation Information
Table 113. Novartis Description and Business Overview
Table 114. Novartis Gabapentin Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 115. Novartis Product
Table 116. Novartis Recent Development
Table 117. Apotex Corporation Information
Table 118. Apotex Description and Business Overview
Table 119. Apotex Gabapentin Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 120. Apotex Product
Table 121. Apotex Recent Development
Table 122. Sun Pharmaceutical Corporation Information
Table 123. Sun Pharmaceutical Description and Business Overview
Table 124. Sun Pharmaceutical Gabapentin Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 125. Sun Pharmaceutical Product
Table 126. Sun Pharmaceutical Recent Development
Table 127. Aurobindo Pharma Corporation Information
Table 128. Aurobindo Pharma Description and Business Overview
Table 129. Aurobindo Pharma Gabapentin Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 130. Aurobindo Pharma Product
Table 131. Aurobindo Pharma Recent Development
Table 132. Intas Corporation Information
Table 133. Intas Description and Business Overview
Table 134. Intas Gabapentin Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 135. Intas Product
Table 136. Intas Recent Development
Table 137. Amneal Corporation Information
Table 138. Amneal Description and Business Overview
Table 139. Amneal Gabapentin Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 140. Amneal Product
Table 141. Amneal Recent Development
Table 142. Marksans Pharma Corporation Information
Table 143. Marksans Pharma Description and Business Overview
Table 144. Marksans Pharma Gabapentin Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 145. Marksans Pharma Product
Table 146. Marksans Pharma Recent Development
Table 147. Glenmark Corporation Information
Table 148. Glenmark Description and Business Overview
Table 149. Glenmark Gabapentin Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 150. Glenmark Product
Table 151. Glenmark Recent Development
Table 152. Alkem Corporation Information
Table 153. Alkem Description and Business Overview
Table 154. Alkem Gabapentin Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 155. Alkem Product
Table 156. Alkem Recent Development
Table 157. Jiangsu Enhua Corporation Information
Table 158. Jiangsu Enhua Description and Business Overview
Table 159. Jiangsu Enhua Gabapentin Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 160. Jiangsu Enhua Product
Table 161. Jiangsu Enhua Recent Development
Table 162. Jiangsu Hengrui Corporation Information
Table 163. Jiangsu Hengrui Description and Business Overview
Table 164. Jiangsu Hengrui Gabapentin Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 165. Jiangsu Hengrui Product
Table 166. Jiangsu Hengrui Recent Development
Table 167. Sailike Corporation Information
Table 168. Sailike Description and Business Overview
Table 169. Sailike Gabapentin Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 170. Sailike Product
Table 171. Sailike Recent Development
Table 172. Gabapentin Market Trends
Table 173. Gabapentin Market Drivers
Table 174. Gabapentin Market Challenges
Table 175. Gabapentin Market Restraints
Table 176. Gabapentin Customers List
Table 177. Gabapentin Distributors List
Table 178. Research Programs/Design for This Report
Table 179. Key Data Information from Secondary Sources
Table 180. Key Data Information from Primary Sources
List of Figures
Figure 1. Gabapentin Product Picture
Figure 2. Global Gabapentin Sales Market Share by Type in 2020 & 2027
Figure 3. Capsule Product Picture
Figure 4. Tablet Product Picture
Figure 5. Global Gabapentin Sales Market Share by Application in 2020 & 2027
Figure 6. Epilepsy
Figure 7. Neuropathic Pain
Figure 8. Restless Legs Syndrome
Figure 9. Others
Figure 10. Gabapentin Report Years Considered
Figure 11. Global Gabapentin Market Size, (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Gabapentin Market Size 2016-2027 (US$ Million)
Figure 13. Global Gabapentin Sales 2016-2027 (M Unit)
Figure 14. Global Gabapentin Market Size Market Share by Region: 2021 Versus 2027
Figure 15. Global Gabapentin Sales Market Share by Region (2016-2021)
Figure 16. Global Gabapentin Sales Market Share by Region in 2020
Figure 17. Global Gabapentin Revenue Market Share by Region (2016-2021)
Figure 18. Global Gabapentin Revenue Market Share by Region in 2020
Figure 19. Global Gabapentin Sales Share by Manufacturer in 2020
Figure 20. The Top 10 and 5 Players Market Share by Gabapentin Revenue in 2020
Figure 21. Gabapentin Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 22. Global Gabapentin Sales Market Share by Type (2016-2021)
Figure 23. Global Gabapentin Sales Market Share by Type in 2020
Figure 24. Global Gabapentin Revenue Market Share by Type (2016-2021)
Figure 25. Global Gabapentin Revenue Market Share by Type in 2020
Figure 26. Global Gabapentin Sales Market Share by Application (2016-2021)
Figure 27. Global Gabapentin Sales Market Share by Application in 2020
Figure 28. Global Gabapentin Revenue Market Share by Application (2016-2021)
Figure 29. Global Gabapentin Revenue Market Share by Application in 2020
Figure 30. Japan Gabapentin Sales Growth Rate 2016-2027 (M Unit)
Figure 31. Japan Gabapentin Revenue Growth Rate 2016-2027 (US$ Million)
Figure 32. Japan Gabapentin Market Share in Global Market 2016-2027
Figure 33. Japan 5 and 10 Largest Gabapentin Players Market Share by Revenue in Gabapentin in 2020
Figure 34. Japan Gabapentin Revenue Share by Type (2016-2021)
Figure 35. Japan Gabapentin Revenue Growth Rate by Type in 2016 & 2020
Figure 36. Japan Gabapentin Revenue Share by Application (2016-2021)
Figure 37. Japan Gabapentin Revenue Growth Rate by Application in 2016 & 2020
Figure 38. North America Gabapentin Sales Growth Rate 2016-2021 (M Unit)
Figure 39. North America Gabapentin Revenue Growth Rate 2016-2021 (US$ Million)
Figure 40. North America Gabapentin Sales Market Share by Country in 2020
Figure 41. North America Gabapentin Revenue Market Share by Country in 2020
Figure 42. U.S. Gabapentin Sales Growth Rate (2016-2021) (M Unit)
Figure 43. U.S. Gabapentin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Canada Gabapentin Sales Growth Rate (2016-2021) (M Unit)
Figure 45. Canada Gabapentin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. Europe Gabapentin Sales Growth Rate 2016-2021 (M Unit)
Figure 47. Europe Gabapentin Revenue Growth Rate 2016-2021 (US$ Million)
Figure 48. Europe Gabapentin Sales Market Share by Country in 2020
Figure 49. Europe Gabapentin Revenue Market Share by Country in 2020
Figure 50. Germany Gabapentin Sales Growth Rate (2016-2021) (M Unit)
Figure 51. Germany Gabapentin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 52. France Gabapentin Sales Growth Rate (2016-2021) (M Unit)
Figure 53. France Gabapentin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 54. U.K. Gabapentin Sales Growth Rate (2016-2021) (M Unit)
Figure 55. U.K. Gabapentin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 56. Italy Gabapentin Sales Growth Rate (2016-2021) (M Unit)
Figure 57. Italy Gabapentin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 58. Russia Gabapentin Sales Growth Rate (2016-2021) (M Unit)
Figure 59. Russia Gabapentin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 60. Asia Pacific Gabapentin Sales Growth Rate 2016-2021 (M Unit)
Figure 61. Asia Pacific Gabapentin Revenue Growth Rate 2016-2021 (US$ Million)
Figure 62. Asia Pacific Gabapentin Sales Market Share by Region in 2020
Figure 63. Asia Pacific Gabapentin Revenue Market Share by Region in 2020
Figure 64. China Gabapentin Sales Growth Rate (2016-2021) (M Unit)
Figure 65. China Gabapentin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 66. Japan Gabapentin Sales Growth Rate (2016-2021) (M Unit)
Figure 67. Japan Gabapentin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 68. South Korea Gabapentin Sales Growth Rate (2016-2021) (M Unit)
Figure 69. South Korea Gabapentin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 70. India Gabapentin Sales Growth Rate (2016-2021) (M Unit)
Figure 71. India Gabapentin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 72. Australia Gabapentin Sales Growth Rate (2016-2021) (M Unit)
Figure 73. Australia Gabapentin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 74. Taiwan Gabapentin Sales Growth Rate (2016-2021) (M Unit)
Figure 75. Taiwan Gabapentin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 76. Indonesia Gabapentin Sales Growth Rate (2016-2021) (M Unit)
Figure 77. Indonesia Gabapentin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 78. Thailand Gabapentin Sales Growth Rate (2016-2021) (M Unit)
Figure 79. Thailand Gabapentin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 80. Malaysia Gabapentin Sales Growth Rate (2016-2021) (M Unit)
Figure 81. Malaysia Gabapentin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 82. Philippines Gabapentin Sales Growth Rate (2016-2021) (M Unit)
Figure 83. Philippines Gabapentin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 84. Vietnam Gabapentin Sales Growth Rate (2016-2021) (M Unit)
Figure 85. Vietnam Gabapentin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 86. Latin America Gabapentin Sales Growth Rate 2016-2021 (M Unit)
Figure 87. Latin America Gabapentin Revenue Growth Rate 2016-2021 (US$ Million)
Figure 88. Latin America Gabapentin Sales Market Share by Country in 2020
Figure 89. Latin America Gabapentin Revenue Market Share by Country in 2020
Figure 90. Mexico Gabapentin Sales Growth Rate (2016-2021) (M Unit)
Figure 91. Mexico Gabapentin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 92. Brazil Gabapentin Sales Growth Rat

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Restless Legs Syndrome Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 112

According to our LPI (LP Information) latest study, the global Restless Legs Syndrome market size was valued at US$ million in 2023. With growing demand in downstream market, the Restless Legs Syndrome is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Restless Legs Syndrome market. Restless Legs Syndrome are expected to show stable growth in the future market. However, product di......

Global Autism Spectrum Disorder Market Research Report 2024 (Status and Outlook)

Published: 15-Dec-2023        Price: US 3200 Onwards        Pages: 110

Report Overview: Autism spectrum disorder is a biologically based neurodevelopmental disorder characterized by persistent deficits in social communication and social interaction and restricted, repetitive patterns of behavior, interests and activities. Diagnosing autism spectrum disorder (ASD) can be difficult, since there is no medical test, like a blood test, to diagnose the disorders. Doctors look at the child's behavior and development to make a diagnosis. Our report studies the market......

Global Epilepsy Therapeutics Market Research Report 2023

Published: 14-Dec-2023        Price: US 2900 Onwards        Pages: 86

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Epilepsy Therapeutics market with multiple angles, which provides sufficient supports to readers' strategy and decision making. By Company - Abbott Laboratories - Cephalon - Novartis - Pfizer - Johnson & Johnson - GlaxoSmithKline - Sanofi - Sunovion Pharmaceuticals......

Global Autism Spectrum Disorder Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 30-Nov-2023        Price: US 3380 Onwards        Pages: 109

Market Overview of Global Autism Spectrum Disorder market: According to our latest research, the global Autism Spectrum Disorder market looks promising in the next 5 years. As of 2022, the global Autism Spectrum Disorder market was estimated at USD 464.19 million, and it's anticipated to reach USD 700.88 million in 2028, with a CAGR of 7.11% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of ......

Global Autism Spectrum Disorder Market Status and Outlook 2023-2028

Published: 24-Nov-2023        Price: US 3160 Onwards        Pages: 109

Autism spectrum disorder (ASD) is a complex developmental condition that involves persistent challenges in social interaction, speech and nonverbal communication, and restricted/repetitive behaviors. The effects of ASD and the severity of symptoms are different in each person. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segmen......

Global Epilepsy Therapeutics Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 16-Nov-2023        Price: US 3380 Onwards        Pages: 112

Market Overview of Global Epilepsy Therapeutics market: According to our latest research, the global Epilepsy Therapeutics market looks promising in the next 5 years. As of 2022, the global Epilepsy Therapeutics market was estimated at USD 11157.84 million, and it's anticipated to reach USD 13510.46 million in 2028, with a CAGR of 3.24% during the forecast years. Epilepsy is a group of neurological disorders characterized by seizures. The onset of a seizure can range from a b......

Global Gabapentin Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 12-Oct-2023        Price: US 3380 Onwards        Pages: 98

Market Overview of Global Gabapentin market: According to our latest research, the global Gabapentin market looks promising in the next 5 years. As of 2022, the global Gabapentin market was estimated at USD 1627.13 million, and it's anticipated to reach USD 1844.92 million in 2028, with a CAGR of 2.12% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Gabapentin market, with a sys......

2023-2031 Report on Global Autism Spectrum Disorder Market by Player, Region, Type, Application and Sales Channel

Published: 09-Oct-2023        Price: US 2500 Onwards        Pages: 89

This report studies the Autism Spectrum Disorder market, covering market size for segment by type (Center-Based, In-Home, etc.), by application (1-14 Years Old, 15-25 Years Old, etc.), by sales channel (Direct Channel, Distribution Channel), by player (Otsuka, Astrazeneca, Pfizer, Eli Lilly, Johnson & Johnson, etc.) and by region (North America, Europe, Asia-Pacific, South America and Middle East & Africa). This report provides detailed historical analysis of global market for Aut......

Global Gabapentin Market Insights, Forecast to 2029

Published: 27-Sep-2023        Price: US 4900 Onwards        Pages: 112

Gabapentin is a medication used to treat epilepsy, neuropathic pain, hot flashes, and restless legs syndrome. In epilepsy, it may be used for those with partial seizures. It is recommended as one of a number of first line medications for the treatment of neuropathic pain in diabetic neuropathy, postherpetic neuralgia, and central neuropathic pain. The global Gabapentin market is projected to grow from US$ 1572.1 million in 2023 to US$ 1749.7 million by 2029, at a Compound Annual Growth Ra......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs